StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.10−0.00 (-0.45%)

Close on Nov 18, 2026Market cap $57.73MP/E –Yield –

OKYO Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for OKYO Pharma

OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More OKYO Pharma figures

See a number that looks wrong?